{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T08:47:43Z","timestamp":1771490863673,"version":"3.50.1"},"reference-count":88,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:sec>\n            <jats:title>Learning Objectives:<\/jats:title>\n            <jats:p>After studying this article, the participant should be able to: 1. List important prognostic features that affect cutaneous squamous cell carcinoma risk. 2. Summarize the changes to the <jats:italic toggle=\"yes\">AJCC Cancer Staging Manual, Eighth Edition<\/jats:italic>, staging system for cutaneous squamous cell carcinoma. 3. Evaluate the draining nodal basin with appropriate imaging modalities. 4. Recommend adjuvant radiation therapy in the correct clinical setting for high-risk tumors. 5. Recognize the currently available treatments for advanced cutaneous squamous cell carcinoma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary:<\/jats:title>\n            <jats:p>This continuing medical education article reviews the features, management, and prognosis of cutaneous squamous cell carcinoma with an emphasis on high-risk squamous cell carcinoma and data from the past 3 years. This review will discuss the primary tumor management, high-risk features of a squamous cell carcinoma, changes to the American Joint Committee on Cancer staging system, and the utility of sentinel lymph node biopsy, and critically review the evidence regarding adjuvant therapy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/prs.0000000000007678","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T04:35:48Z","timestamp":1614400548000},"page":"492-504","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["New Developments in the Management of Cutaneous Squamous Cell Carcinoma"],"prefix":"10.1097","volume":"147","author":[{"given":"Thomas J.","family":"Knackstedt","sequence":"first","affiliation":[{"name":"From the Department of Dermatology MetroHealth Hospital; School of Medicine, Case Western Reserve University; the Department of Plastic and Reconstructive Surgery, Cleveland Clinic Foundation; and the College of Medicine and Life Sciences, University of Toledo."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca W.","family":"Knackstedt","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology MetroHealth Hospital; School of Medicine, Case Western Reserve University; the Department of Plastic and Reconstructive Surgery, Cleveland Clinic Foundation; and the College of Medicine and Life Sciences, University of Toledo."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Djohan","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology MetroHealth Hospital; School of Medicine, Case Western Reserve University; the Department of Plastic and Reconstructive Surgery, Cleveland Clinic Foundation; and the College of Medicine and Life Sciences, University of Toledo."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raisal","family":"Djohan","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology MetroHealth Hospital; School of Medicine, Case Western Reserve University; the Department of Plastic and Reconstructive Surgery, Cleveland Clinic Foundation; and the College of Medicine and Life Sciences, University of Toledo."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian R.","family":"Gastman","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology MetroHealth Hospital; School of Medicine, Case Western Reserve University; the Department of Plastic and Reconstructive Surgery, Cleveland Clinic Foundation; and the College of Medicine and Life Sciences, University of Toledo."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Crowe","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology MetroHealth Hospital; School of Medicine, Case Western Reserve University; the Department of Plastic and Reconstructive Surgery, Cleveland Clinic Foundation; and the College of Medicine and Life Sciences, University of Toledo."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,2,23]]},"reference":[{"key":"R1-20250501","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/jamadermatol.2015.1187","article-title":"Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S. population, 2012.","volume":"151","author":"Rogers","year":"2015","journal-title":"JAMA Dermatol"},{"key":"R2-20250501","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.mayocp.2017.02.015","article-title":"Incidence and trends of basal cell carcinoma and cutaneous squamous cell carcinoma: A population-based study in Olmsted County, Minnesota, 2000 to 2010.","volume":"92","author":"Muzic","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"R3-20250501","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/jso.23155","article-title":"The incidence of metastasis from cutaneous squamous cell carcinoma and the impact of its risk factors.","volume":"106","author":"Brougham","year":"2012","journal-title":"J Surg Oncol"},{"key":"R4-20250501","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jaad.2012.11.037","article-title":"Cutaneous squamous cell carcinoma: Estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012.","volume":"68","author":"Karia","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"R5-20250501","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1186\/1471-2407-12-417","article-title":"Patterns and timing of sunlight exposure and risk of basal cell and squamous cell carcinomas of the skin: A case-control study.","volume":"12","author":"Iannacone","year":"2012","journal-title":"BMC Cancer"},{"issue":"Suppl 8","key":"R6-20250501","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/jdv.15967","article-title":"Incidence and mortality for cutaneous squamous cell carcinoma: Comparison across three continents.","volume":"33","author":"Stang","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R7-20250501","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0190-9622(97)70265-2","article-title":"Actinic keratoses.","volume":"36","author":"Callen","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"R8-20250501","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1002\/cncr.24284","article-title":"Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial.","volume":"115","author":"Criscione","year":"2009","journal-title":"Cancer"},{"key":"R9-20250501","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(88)91658-3","article-title":"Malignant transformation of solar keratoses to squamous cell carcinoma.","volume":"1","author":"Marks","year":"1988","journal-title":"Lancet"},{"key":"R10-20250501","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jaad.2019.01.038","article-title":"Risk factors for keratinocyte carcinoma skin cancer in nonwhite individuals: A retrospective analysis.","volume":"81","author":"Nadhan","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"R11-20250501","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1200\/JCO.2001.19.1.231","article-title":"Relation between smoking and skin cancer.","volume":"19","author":"De Hertog","year":"2001","journal-title":"J Clin Oncol"},{"key":"R12-20250501","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/jamaoto.2019.3751","article-title":"Association of immunosuppression with outcomes of patients with cutaneous squamous cell carcinoma of the head and neck.","volume":"146","author":"Tam","year":"2020","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"R13-20250501","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1001\/jamadermatol.2016.4920","article-title":"Incidence of and risk factors for skin cancer in organ transplant recipients in the United States.","volume":"153","author":"Garrett","year":"2017","journal-title":"JAMA Dermatol"},{"key":"R14-20250501","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1001\/jamadermatol.2017.2984","article-title":"Long-term change in the risk of skin cancer after organ transplantation: A population-based nationwide cohort study.","volume":"153","author":"Rizvi","year":"2017","journal-title":"JAMA Dermatol"},{"key":"R15-20250501","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1001\/jamadermatol.2013.6249","article-title":"Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia.","volume":"150","author":"Velez","year":"2014","journal-title":"JAMA Dermatol"},{"key":"R16-20250501","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jaad.2014.10.028","article-title":"Increased incidence and recurrence rates of nonmelanoma skin cancer in patients with non-Hodgkin lymphoma: A Rochester Epidemiology Project population-based study in Minnesota.","volume":"72","author":"Brewer","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"R17-20250501","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.clon.2019.08.005","article-title":"Management of non-melanoma skin cancer in transplant recipients.","volume":"31","author":"Collins","year":"2019","journal-title":"Clin Oncol (R Coll Radiol.)"},{"key":"R18-20250501","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1001\/jamadermatol.2018.4983","article-title":"Association of HLA antigen mismatch with risk of developing skin cancer after solid-organ transplant.","volume":"155","author":"Gao","year":"2019","journal-title":"JAMA Dermatol"},{"key":"R19-20250501","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/jamadermatol.2016.5703","article-title":"Association of human papillomavirus vaccine with the development of keratinocyte carcinomas.","volume":"153","author":"Nichols","year":"2017","journal-title":"JAMA Dermatol"},{"key":"R20-20250501","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/jamadermatol.2018.1748","article-title":"Combined systemic and intratumoral administration of human papillomavirus vaccine to treat multiple cutaneous basaloid squamous cell carcinomas.","volume":"154","author":"Nichols","year":"2018","journal-title":"JAMA Dermatol"},{"key":"R21-20250501","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jamadermatol.2015.4994","article-title":"Risk factors for cutaneous squamous cell carcinoma recurrence, metastasis, and disease-specific death: A systematic review and meta-analysis.","volume":"152","author":"Thompson","year":"2016","journal-title":"JAMA Dermatol"},{"key":"R22-20250501","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/0190-9622(92)70144-5","article-title":"Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: Implications for treatment modality selection.","volume":"26","author":"Rowe","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"R23-20250501","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jaad.2019.10.017","article-title":"A matched-pair study of cutaneous squamous cell carcinomas with and without lymphovascular invasion.","volume":"82","author":"Levoska","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"R24-20250501","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.ijrobp.2018.06.143","article-title":"Margin status, lymphovascular invasion, and number of neck levels involved predict distant failure in p16+ oropharyngeal squamous cell carcinoma (OPSCC) following transoral robotic surgery (TORS).","volume":"102","author":"Schonewolf","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R25-20250501","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/jamadermatol.2013.746","article-title":"Outcomes of primary cutaneous squamous cell carcinoma with perineural invasion: An 11-year cohort study.","volume":"149","author":"Carter","year":"2013","journal-title":"JAMA Dermatol"},{"key":"R26-20250501","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/jamadermatol.2017.1680","article-title":"Clinical and incidental perineural invasion of cutaneous squamous cell carcinoma: A systematic review and pooled analysis of outcomes data.","volume":"153","author":"Karia","year":"2017","journal-title":"JAMA Dermatol"},{"key":"R27-20250501","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1200\/JCO.2012.48.5326","article-title":"Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women\u2019s Hospital tumor staging for cutaneous squamous cell carcinoma.","volume":"32","author":"Karia","year":"2014","journal-title":"J Clin Oncol"},{"key":"R28-20250501","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3322\/caac.21388","article-title":"The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging.","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"R29-20250501","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/DSS.0000000000001774","article-title":"Stratification of poor outcomes for cutaneous squamous cell carcinoma in immunosuppressed patients using the American Joint Committee on Cancer Eighth Edition and Brigham and Women\u2019s Hospital staging systems.","volume":"45","author":"Blechman","year":"2019","journal-title":"Dermatol Surg"},{"key":"R30-20250501","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PAP.0000000000000157","article-title":"Cutaneous squamous cell carcinoma: Review of the Eighth Edition of the American Joint Committee on Cancer staging guidelines, prognostic factors, and histopathologic variants.","volume":"24","author":"Motaparthi","year":"2017","journal-title":"Adv Anat Pathol"},{"key":"R31-20250501","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jaad.2018.06.060","article-title":"Comparing the eighth and the seventh editions of the American Joint Committee on Cancer staging system and the Brigham and Women\u2019s Hospital alternative staging system for cutaneous squamous cell carcinoma: Implications for clinical practice.","volume":"80","author":"Ca\u00f1ueto","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"R32-20250501","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jaad.2018.08.018","article-title":"Comparison of tumor staging systems for cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia.","volume":"80","author":"Inda","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"R33-20250501","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/jamadermatol.2017.3960","article-title":"Comparison of tumor classifications for cutaneous squamous cell carcinoma of the head and neck in the 7th vs 8th edition of the AJCC Cancer Staging Manual.","volume":"154","author":"Karia","year":"2018","journal-title":"JAMA Dermatol"},{"key":"R34-20250501","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jaad.2019.06.1303","article-title":"Long-term clinical outcomes of patients with invasive cutaneous squamous cell carcinoma treated with Mohs micrographic surgery: A 5-year, multicenter, prospective cohort study.","volume":"82","author":"Tschetter","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"R35-20250501","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1245\/s10434-018-6340-x","article-title":"Analysis and comparison of the 8th Edition American Joint Committee on Cancer (AJCC) nodal staging system in cutaneous and oral squamous cell cancer of the head and neck.","volume":"25","author":"Moeckelmann","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"R36-20250501","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/hed.23602","article-title":"Assessment of the new nodal classification for cutaneous squamous cell carcinoma and its effect on patient stratification.","volume":"37","author":"Brunner","year":"2015","journal-title":"Head Neck"},{"key":"R37-20250501","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/jso.24883","article-title":"Predictive value of the 8th edition American Joint Commission Cancer (AJCC) nodal staging system for patients with cutaneous squamous cell carcinoma of the head and neck.","volume":"117","author":"Liu","year":"2018","journal-title":"J Surg Oncol"},{"key":"R38-20250501","doi-asserted-by":"crossref","first-page":"5825","DOI":"10.21873\/anticanres.12923","article-title":"Suboptimal outcomes in cutaneous squamous cell cancer of the head and neck with nodal metastases.","volume":"38","author":"Varra","year":"2018","journal-title":"Anticancer Res"},{"key":"R39-20250501","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/hed.25599","article-title":"A critical analysis of the prognostic performance of the 8th edition American Joint Committee on Cancer staging for metastatic cutaneous squamous cell carcinoma of the head and neck.","volume":"41","author":"Sood","year":"2019","journal-title":"Head Neck"},{"key":"R40-20250501","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jamadermatol.2013.2139","article-title":"Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: A 10-year, single-institution cohort study.","volume":"149","author":"Schmults","year":"2013","journal-title":"JAMA Dermatol"},{"key":"R41-20250501","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.jaad.2019.12.049","article-title":"Outcomes in intermediate-risk squamous cell carcinomas treated with Mohs micrographic surgery compared with wide local excision.","volume":"82","author":"Xiong","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"R42-20250501","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0190-9622(92)70074-P","article-title":"Squamous cell carcinoma of the skin (excluding lip and oral mucosa).","volume":"26","author":"Johnson","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"R43-20250501","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jaad.2018.10.042","article-title":"Present and future perspectives of photodynamic therapy for cutaneous squamous cell carcinoma.","volume":"80","author":"Keyal","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"R44-20250501","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.det.2019.05.003","article-title":"Nonsurgical treatments for nonmelanoma skin cancer.","volume":"37","author":"Collins","year":"2019","journal-title":"Dermatol Clin"},{"key":"R46-20250501","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jaad.2017.10.007","article-title":"Guidelines of care for the management of cutaneous squamous cell carcinoma.","volume":"78","author":"Kim","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"R47-20250501","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/jdv.16167","article-title":"Cutaneous squamous cell carcinoma with incomplete margins demonstrate higher tumour grade on re-excision.","volume":"34","author":"Spyropoulou","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R48-20250501","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0190-9622(92)70178-I","article-title":"Surgical margins for excision of primary cutaneous squamous cell carcinoma.","volume":"27","author":"Brodland","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"R49-20250501","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s40463-019-0374-3","article-title":"Pathological margins and advanced cutaneous squamous cell carcinoma of the head and neck.","volume":"48","author":"Phillips","year":"2019","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"R50-20250501","doi-asserted-by":"crossref","first-page":"2233;","DOI":"10.1097\/01.PRS.0000123625.76158.73","article-title":"Nonmelanoma of the skin and Mohs surgery.","volume":"113","author":"Pennington","year":"2004","journal-title":"Plast Reconstr Surg"},{"key":"R51-20250501","article-title":"The \u201crule of 10s\u201d versus the \u201crule of 2s\u201d: High complication rates after conventional excision with postoperative margin assessment of specialty site versus trunk and proximal extremity melanomas.","author":"Rzepecki","journal-title":"J Am Acad Dermatol"},{"key":"R52-20250501","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jaad.2012.06.009","article-title":"AAD\/ACMS\/ASDSA\/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: A report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery.","volume":"67","author":"Connolly","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"R53-20250501","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1111\/j.1524-4725.2010.01576.x","article-title":"Mohs surgery is effective for high-risk cutaneous squamous cell carcinoma.","volume":"36","author":"Pugliano-Mauro","year":"2010","journal-title":"Dermatol Surg"},{"key":"R54-20250501","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jaad.2018.09.015","article-title":"Clinical outcomes in high-risk squamous cell carcinoma patients treated with Mohs micrographic surgery alone.","volume":"80","author":"Marrazzo","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"R55-20250501","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jaad.2019.06.1303","article-title":"Long-term clinical outcomes of patients with invasive cutaneous squamous cell carcinoma treated with Mohs micrographic surgery: A 5-year, multicenter, prospective cohort study.","volume":"82","author":"Tschetter","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"R56-20250501","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJMoa1506197","article-title":"A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention.","volume":"373","author":"Chen","year":"2015","journal-title":"N Engl J Med"},{"key":"R57-20250501","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1097\/DSS.0000000000002072","article-title":"Use of topical and systemic retinoids in solid organ transplant recipients: Update and review of the current literature.","volume":"45","author":"Herold","year":"2019","journal-title":"Dermatol Surg"},{"key":"R58-20250501","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.det.2019.02.004","article-title":"Topical and systemic modalities for chemoprevention of nonmelanoma skin cancer.","volume":"37","author":"Nemer","year":"2019","journal-title":"Dermatol Clin"},{"key":"R59-20250501","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.amjoto.2017.01.035","article-title":"Rate of regional nodal metastases of cutaneous squamous cell carcinoma in the immunosuppressed patient.","volume":"38","author":"McLaughlin","year":"2017","journal-title":"Am J Otolaryngol"},{"key":"R60-20250501","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jaad.2018.09.006","article-title":"Nodal staging of high-risk cutaneous squamous cell carcinoma.","volume":"81","author":"Fox","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"R61-20250501","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ejrad.2007.02.037","article-title":"Detection of lymph node metastases in head and neck cancer: A meta-analysis comparing US, USgFNAC, CT and MR imaging.","volume":"64","author":"de Bondt","year":"2007","journal-title":"Eur J Radiol"},{"key":"R62-20250501","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00238-018-1432-1","article-title":"Utility of ultrasound of the lymph nodes in patients with high-risk cutaneous squamous cell carcinoma.","volume":"41","author":"Haldrup","year":"2018","journal-title":"Eur J Plast Surg"},{"key":"R63-20250501","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jaad.2016.08.051","article-title":"The positive impact of radiologic imaging on high-stage cutaneous squamous cell carcinoma management.","volume":"76","author":"Ruiz","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"R64-20250501","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jaad.2019.10.067","article-title":"Detection of subclinical disease with baseline and surveillance imaging in high-risk cutaneous squamous cell carcinomas.","volume":"82","author":"Maher","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"R65-20250501","first-page":"410","article-title":"High-risk cutaneous squamous cell carcinoma without palpable lymphadenopathy: Is there a therapeutic role for elective neck dissection?","volume":"33","author":"Martinez","year":"2007","journal-title":"Dermatol Surg"},{"key":"R66-20250501","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejca.2019.02.004","article-title":"The prognostic value of sentinel lymph nodes on distant metastasis-free survival in patients with high-risk squamous cell carcinoma.","volume":"111","author":"Jansen","year":"2019","journal-title":"Eur J Cancer"},{"key":"R67-20250501","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/jamadermatol.2013.6675","article-title":"Staging for cutaneous squamous cell carcinoma as a predictor of sentinel lymph node biopsy results: Meta-analysis of American Joint Committee on Cancer criteria and a proposed alternative system.","volume":"150","author":"Schmitt","year":"2014","journal-title":"JAMA Dermatol"},{"key":"R68-20250501","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jaad.2015.03.039","article-title":"High-risk cutaneous squamous cell carcinoma and the emerging role of sentinel lymph node biopsy: A literature review.","volume":"73","author":"Navarrete-Dechent","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"R69-20250501","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1177\/0194599813511949","article-title":"Utility of head and neck cutaneous squamous cell carcinoma sentinel node biopsy: A systematic review.","volume":"150","author":"Ahmed","year":"2014","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R70-20250501","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1245\/s10434-019-07865-z","article-title":"Sentinel node biopsy in 105 high-risk cutaneous SCCs of the head and neck: Results of a multicenter prospective study.","volume":"26","author":"Mooney","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"R71-20250501","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/lary.27881","article-title":"Sentinel lymph node biopsy for high-risk cutaneous squamous cell carcinoma of the head and neck.","volume":"130","author":"Wu","year":"2020","journal-title":"Laryngoscope"},{"key":"R72-20250501","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jss.2019.03.040","article-title":"Cost-effectiveness of sentinel lymph node biopsy for head and neck cutaneous squamous cell carcinoma.","volume":"241","author":"Quinn","year":"2019","journal-title":"J Surg Res"},{"key":"R73-20250501","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/jamaoto.2018.3650","article-title":"Association of adjuvant radiation therapy with survival in patients with advanced cutaneous squamous cell carcinoma of the head and neck.","volume":"145","author":"Harris","year":"2019","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"R74-20250501","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jaad.2019.07.048","article-title":"Evaluation of the utility of localized adjuvant radiation for node-negative primary cutaneous squamous cell carcinoma with clear histologic margins.","volume":"82","author":"Ruiz","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"R75-20250501","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/DSS.0000000000001827","article-title":"Outcomes of adjuvant radiotherapy following negative surgical margins for cutaneous squamous cell carcinoma.","volume":"45","author":"Miller","year":"2019","journal-title":"Dermatol Surg"},{"key":"R76-20250501","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1002\/cncr.30601","article-title":"A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.","volume":"123","author":"Manyam","year":"2017","journal-title":"Cancer"},{"key":"R77-20250501","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/jamadermatol.2018.5453","article-title":"Association of disease recurrence with survival outcomes in patients with cutaneous squamous cell carcinoma of the head and neck treated with multimodality therapy.","volume":"155","author":"Sun","year":"2019","journal-title":"JAMA Dermatol"},{"key":"R78-20250501","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/hed.23684","article-title":"Postoperative concurrent chemotherapy and radiotherapy for high-risk cutaneous squamous cell carcinoma of the head and neck.","volume":"37","author":"Tanvetyanon","year":"2015","journal-title":"Head Neck"},{"key":"R79-20250501","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1200\/JCO.2017.77.0941","article-title":"Postoperative concurrent chemoradiotherapy versus postoperative radiotherapy in high-risk cutaneous squamous cell carcinoma of the head and neck: The randomized phase III TROG 05.01 trial.","volume":"36","author":"Porceddu","year":"2018","journal-title":"J Clin Oncol"},{"key":"R80-20250501","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hed.24662","article-title":"Prospective study of definitive chemoradiation in locally or regionally advanced squamous cell carcinoma of the skin.","volume":"39","author":"Nottage","year":"2017","journal-title":"Head Neck"},{"key":"R81-20250501","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/jdv.16007","article-title":"Stage IV cutaneous squamous cell carcinoma: Treatment outcomes in a series of 42 patients.","volume":"34","author":"Chapalain","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R82-20250501","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1200\/JCO.2010.34.1735","article-title":"Phase II study of cetuximab as first-line single-drug therapy in patients with unresectable squamous cell carcinoma of the skin.","volume":"29","author":"Maubec","year":"2011","journal-title":"J Clin Oncol"},{"key":"R83-20250501","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/DSS.0000000000001755","article-title":"Cetuximab as a component of multimodality treatment of high-risk cutaneous squamous cell carcinoma: A retrospective analysis from a single tertiary academic medical center.","volume":"45","author":"Trodello","year":"2019","journal-title":"Dermatol Surg"},{"key":"R84-20250501","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/COC.0000000000000228","article-title":"Concurrent radiotherapy with cetuximab or platinum-based chemotherapy for locally advanced cutaneous squamous cell carcinoma of the head and neck.","volume":"41","author":"Lu","year":"2018","journal-title":"Am J Clin Oncol"},{"key":"R85-20250501","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1805131","article-title":"PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma.","volume":"379","author":"Migden","year":"2018","journal-title":"N Engl J Med"},{"key":"R86-20250501","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S1470-2045(19)30728-4","article-title":"Cemiplimab in locally advanced cutaneous squamous cell carcinoma: Results from an open-label, phase 2, single-arm trial.","volume":"21","author":"Migden","year":"2020","journal-title":"Lancet Oncol"},{"key":"R87-20250501","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2217\/fon-2019-0762","article-title":"CASE (CemiplimAb-rwlc Survivorship and Epidemiology) study in advanced cutaneous squamous cell carcinoma.","volume":"16","author":"Migden","year":"2020","journal-title":"Future Oncol"},{"key":"R88-20250501","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jaad.2019.05.077","article-title":"Programmed cell death 1 protein and programmed death-ligand 1 inhibitors in the treatment of nonmelanoma skin cancer: A systematic review.","volume":"82","author":"Choi","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 8","key":"R89-20250501","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/jdv.15845","article-title":"Advanced cutaneous squamous cell carcinoma: Real world data of patient profiles and treatment patterns.","volume":"33","author":"Amaral","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Plastic &amp; Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PRS.0000000000007678","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:11:08Z","timestamp":1746144668000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PRS.0000000000007678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,23]]},"references-count":88,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/prs.0000000000007678","relation":{},"ISSN":["0032-1052"],"issn-type":[{"value":"0032-1052","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,23]]}}}